Does Eosinophilic Granulomatosis with Polyangiitis (EGPA) affect the pleura and how commonly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pleural Involvement in EGPA

Yes, EGPA can affect the pleura, but pleural effusions are an uncommon manifestation of the disease, occurring much less frequently than other pulmonary manifestations such as lung infiltrates.

Frequency of Pleural Involvement

Pleural effusions are rare in EGPA and are not listed among the common organ manifestations in current evidence-based guidelines. 1 The 2023 Nature Reviews Rheumatology guideline specifically identifies lung infiltrates as common (occurring in 40-50% of patients), but does not mention pleural involvement among the typical clinical features. 1

Common Pulmonary Manifestations vs. Pleural Disease

The typical pulmonary involvement in EGPA includes:

  • Lung infiltrates occur in 40-50% of patients and are often multiple, migratory, and responsive to systemic glucocorticoids 1
  • Asthma is present in >90% of EGPA patients, representing the most common respiratory manifestation 2, 3
  • Bilateral pulmonary infiltrates are characteristic, occurring in approximately 86% of cases 3

In contrast, pleural effusions are documented as "an uncommon manifestation of EGPA" in case reports. 4 When pleural effusions do occur, they may present alongside other pulmonary findings such as nodules and infiltrates. 4

Clinical Context

Cardiac involvement (myocarditis and pericarditis) is explicitly mentioned as an organ manifestation in EGPA, 1 and pericarditis could theoretically lead to pericardial effusions. However, isolated pleural disease is not emphasized in the major guidelines as a typical feature.

When evaluating a patient with suspected EGPA and pleural effusions, clinicians should consider that this represents an atypical presentation and ensure thorough evaluation for the more common manifestations including asthma, peripheral eosinophilia, lung infiltrates, peripheral neuropathy (50-70%), skin lesions, and cardiac involvement. 1, 2

Diagnostic Implications

The absence of pleural involvement from the ACR classification criteria (which include asthma, eosinophilia >10%, neuropathy, non-fixed lung infiltrates, paranasal sinus abnormalities, and histological evidence of extravascular eosinophils) further underscores that pleural disease is not a defining or common feature of EGPA. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Eosinophilic Granulomatosis with Polyangiitis Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Eosinophilic Granulomatosis with Polyangiitis (EGPA) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the differences in manifestations between Polyarteritis Nodosa (PAN) and Eosinophilic Granulomatosis with Polyangiitis (EGPA)?
What are the pathophysiology, signs, and symptoms of Eosinophilic Granulomatosis with Polyangiitis (eGPA)?
What is the most likely diagnosis and treatment for a patient with asthma, allergic rhinitis, and bilateral non-cavitary infiltrates on chest radiography, with a family history of Churg-Strauss vasculitis (Eosinophilic Granulomatosis with Polyangiitis, EGPA)?
What's the treatment approach for GPA (Granulomatosis with Polyangiitis) vs EGPA (Eosinophilic Granulomatosis with Polyangiitis) with a 5-point diagnostic difference?
What is the fisiopatología, laboratory exams, and treatment for Eosinophilic Granulomatosis with Polyangiitis (EGPA), based on Kidney Disease: Improving Global Outcomes (KDIGO) guidelines and recent treatments?
What is the best approach to evaluate and manage an interesting case in obstetrics and gynecology (OBGYN) for a female patient of reproductive age with potential pregnancy-related complications or gynecological conditions?
What is the cause and management of a right pleural effusion in a patient with acute pancreatitis, with pleural fluid analysis showing leukocytosis (Total Leukocyte Count (TLC) elevation), elevated protein, and hypoglycemia (low glucose)?
What is the primary concern for a patient with hypercalcemia, normal potassium, normal serum sodium, and polyuria, with no history of Diabetes Mellitus (DM) or Diabetes Insipidus (DI)?
What are some interesting cases to consider for a female patient of reproductive age with potential pregnancy-related complications or gynecological conditions, such as recurrent miscarriages or polycystic ovary syndrome (PCOS)?
What are the other causes of eosinophilic effusion in a patient, aside from Eosinophilic Granulomatosis with Polyangiitis (EGPA)?
Can piperacillin-tazobactam (Pip-Taz) be used to treat a patient with acute pancreatitis and an infected right pleural effusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.